IS8200A - Efnasmíðað gen sem táknar mótefnisvaka mennsks húðþekjuvaxtarþáttar 2/NEU og notkun á því - Google Patents

Efnasmíðað gen sem táknar mótefnisvaka mennsks húðþekjuvaxtarþáttar 2/NEU og notkun á því

Info

Publication number
IS8200A
IS8200A IS8200A IS8200A IS8200A IS 8200 A IS8200 A IS 8200A IS 8200 A IS8200 A IS 8200A IS 8200 A IS8200 A IS 8200A IS 8200 A IS8200 A IS 8200A
Authority
IS
Iceland
Prior art keywords
neu
antigen
growth factor
epidermal growth
synthetic gene
Prior art date
Application number
IS8200A
Other languages
English (en)
Inventor
Gallo Pasquale
Monaci Paolo
Nuzzo Maurizio
Original Assignee
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa filed Critical Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa
Publication of IS8200A publication Critical patent/IS8200A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8200A 2003-07-21 2005-12-27 Efnasmíðað gen sem táknar mótefnisvaka mennsks húðþekjuvaxtarþáttar 2/NEU og notkun á því IS8200A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48923703P 2003-07-21 2003-07-21
PCT/EP2004/008234 WO2005012527A1 (en) 2003-07-21 2004-07-20 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof

Publications (1)

Publication Number Publication Date
IS8200A true IS8200A (is) 2005-12-27

Family

ID=34115329

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8200A IS8200A (is) 2003-07-21 2005-12-27 Efnasmíðað gen sem táknar mótefnisvaka mennsks húðþekjuvaxtarþáttar 2/NEU og notkun á því

Country Status (14)

Country Link
US (2) US20070111957A1 (is)
EP (1) EP1649020B1 (is)
JP (1) JP4772674B2 (is)
KR (1) KR101141507B1 (is)
CN (2) CN100558894C (is)
AU (1) AU2004261724B2 (is)
CA (1) CA2532460C (is)
IL (1) IL173208A (is)
IS (1) IS8200A (is)
NO (1) NO20060813L (is)
NZ (1) NZ544543A (is)
RU (1) RU2397249C2 (is)
WO (1) WO2005012527A1 (is)
ZA (1) ZA200600248B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3061462B1 (en) 2007-07-02 2019-02-27 Etubics Corporation Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
GB2484058A (en) * 2009-12-01 2012-04-04 Uni Konstanz Prostate cancer DNA vaccine
US9605276B2 (en) 2012-08-24 2017-03-28 Etubics Corporation Replication defective adenovirus vector in vaccination
CN103555765B (zh) * 2013-05-30 2015-01-07 中南大学湘雅医院 一种转录调控肿瘤靶向复制溶瘤腺病毒载体、携带治疗基因腺病毒及其制备方法和应用
SG10201808825XA (en) * 2014-04-10 2018-11-29 Seattle Childrens Hospital Dba Seattle Childrens Res Inst Defined composition gene modified t-cell products
CA2974237C (en) 2015-01-09 2021-07-20 Etubics Corporation Methods and compositions for combination immunotherapy
WO2016112188A1 (en) 2015-01-09 2016-07-14 Etubics Corporation Methods and compositions for ebola virus vaccination
US11149087B2 (en) 2015-04-20 2021-10-19 Etubics Corporation Methods and compositions for combination immunotherapy
US11458167B2 (en) 2015-08-07 2022-10-04 Seattle Children's Hospital Bispecific CAR T-cells for solid tumor targeting
US11266726B2 (en) 2015-10-30 2022-03-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for the treatment of HER2-expressing solid tumors
US11408005B2 (en) 2016-12-12 2022-08-09 Seattle Children's Hospital Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
EP3691675A1 (en) * 2017-08-24 2020-08-12 Bavarian Nordic A/S Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an antibody
CN112941132B (zh) * 2021-05-17 2021-07-23 烟台市华昕生物医药科技有限公司 一种利用大肠杆菌表达寡肽-1的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869445A (en) * 1993-03-17 1999-02-09 University Of Washington Methods for eliciting or enhancing reactivity to HER-2/neu protein
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
WO1995030331A1 (en) * 1994-05-05 1995-11-16 The Trustees Of The University Of Pennsylvania Compositions and methods of treating tumors
IT1276662B1 (it) * 1995-04-04 1997-11-03 Uni Degli Studi Camerino Vaccini polinucleotidici
TR200102191T2 (tr) * 1999-01-29 2001-12-21 Corixa Corporation HER-2/neu füzyon proteinleri.
JP2004522412A (ja) * 2000-08-14 2004-07-29 コリクサ コーポレイション Ｈｅｒ−２／ｎｅｕ−関連悪性腫瘍の治療および診断のための組成物および方法
CA2422882A1 (en) 2000-09-15 2002-03-21 Merck & Co., Inc. Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
CN1164330C (zh) * 2001-07-19 2004-09-01 中国医学科学院基础医学研究所 一种重组复制缺陷型腺病毒载体狂犬病毒基因工程疫苗
KR100555211B1 (ko) * 2002-07-16 2006-03-03 주식회사 팬제노믹스 항암효과를 갖는 Ｈｅｒ-２/ｎｅｕ ＤＮＡ 백신
WO2004041065A2 (en) * 2002-10-30 2004-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS
US7282365B2 (en) 2003-01-03 2007-10-16 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Rhesus HER2/neu, nucleotides encoding same, and uses thereof

Also Published As

Publication number Publication date
ZA200600248B (en) 2007-03-28
CA2532460A1 (en) 2005-02-10
KR101141507B1 (ko) 2012-05-08
EP1649020A1 (en) 2006-04-26
CN100558894C (zh) 2009-11-11
RU2006105195A (ru) 2006-06-27
CN1826409A (zh) 2006-08-30
IL173208A0 (en) 2006-06-11
AU2004261724A1 (en) 2005-02-10
WO2005012527A9 (en) 2006-03-02
AU2004261724B2 (en) 2010-06-17
US20090098604A1 (en) 2009-04-16
KR20060052852A (ko) 2006-05-19
JP4772674B2 (ja) 2011-09-14
US7662586B2 (en) 2010-02-16
IL173208A (en) 2014-06-30
NZ544543A (en) 2009-03-31
US20070111957A1 (en) 2007-05-17
NO20060813L (no) 2006-03-20
JP2006527989A (ja) 2006-12-14
WO2005012527A1 (en) 2005-02-10
RU2397249C2 (ru) 2010-08-20
CN101173282B (zh) 2011-04-06
CA2532460C (en) 2012-04-24
EP1649020B1 (en) 2017-01-11
CN101173282A (zh) 2008-05-07

Similar Documents

Publication Publication Date Title
IS8200A (is) Efnasmíðað gen sem táknar mótefnisvaka mennsks húðþekjuvaxtarþáttar 2/NEU og notkun á því
AU2003216462A8 (en) Suture fasteners and methods of use
EP1643944A4 (en) EXTENSIBLE FABRIC SUPPORTING ELEMENT AND METHOD OF FORMING THE SUPPORTING ELEMENT
IL168058A0 (en) Antibodies that bind celi-associated ca 125/0722p and methods of use thereof
EP1503768A4 (en) INOSITOLPYROPHOSPHATES AND DERENY APPLICATION PROCEDURES
IL176594A0 (en) Modified human four helical bundle polypeptides and their uses
LT2368907T (lt) Anti-abeta antikūnai ir jų panaudojimas
AU2003216482A8 (en) Msras as modifiers of the p53 pathway and methods of use
AU2003236497A8 (en) Expandable blood pump and related methods
IS6999A (is) Mótefni sem blokka prótínið Cripto og notkun þeirra
IL160550A0 (en) Plaster for the treatment of dysfunctions and disorders of nail growth
ATE412013T1 (de) Anti-osteopontin-antikörper und dessen verwendung
IL166440A0 (en) Method of non-invasive ambulatory exploration for assessing the digestive motricity and/or transit and corresponding system
AU2003256904A8 (en) Plurality of bags and method of making the same
DK1375647T3 (da) Kunstig dermis og fremstillingsfremgangsmåde dertil
GB0402099D0 (en) Method of attaching hair-thickening hair material and hair-thickening hair material fixture used for the method
DE60225449D1 (de) Wildlederartiges kunstleder und verfahren zu dessen herstellung
GB0321805D0 (en) Human tumour growth patterns
AU2003231790A8 (en) Articulating suturing device and method
AU2003239610A8 (en) Tiled biochips and the methods of making the same
AU2002365202A8 (en) Synthetic genes for malarial proteins and methods of use
AU2003276844A8 (en) Formulations of modified antibodies and methods of making the same
AU2003286142A1 (en) Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis
AU2003274911A8 (en) Mrbs as modifiers of the rb pathway and methods of use
AU2003212142A8 (en) Downregulation of ca 125 tumor antigen and uses thereof